Cannabist Gainesville
Dispensary
In-store purchases only
Medical patients only
Super nice dispensary with A+ staff
The selection is a bit limited right now since they just opened. Had a great experience there. Staff is knowledgeable and very friendly. Will definitely be coming back.
Thank you for your review! We are pleased that you are happy with our knowledgeable and professional staff.
Official response
Idk
Erica has been the most helpful out of most of the dispensaries I have been too totally an awesome experience
Kalechip0610Boca Raton
Best service and amazing carts
Cannabist in Gainesville is amazing. They have the most vape options by far with over 50 choices of cartridges. The staff is super friendly and knowledgeable of the products and the feelings associated with them.
AdamhcGainesville
Largest selection in Gainsville
Very large store and the the Products were very smooth. Prerolls packed nicely nothing was wasted.
ImJustAChickenNuggetGainesville
Excellence
Cannabist is my favorite dispensary. A few times my curator was Isabel Mercedes. Since I hardly can walk, she brought a chair so I could sit and make my shopping a good experience! She’s so profesional and caring. She orients me about new products for my condition. She is a great assess to your company. She’s also bilingual which makes it easy to understand and get more products which help me a lot.
CorozalGainesville
The customer service
It was an very education visit. It’s always a good vibe from the hostess and the staff.
nyboi352Eustis
Excellent!
It was my first time going to Columbia and was surprised with the quantity and quality of the products!!! The staff is well prepared and knowledgeable. I loved it!!!
WMUser220358138Gainesville
Yay!! So glad you had a great experience, thank you so much for leaving us a review. We look forward to seeing you again!
Official response
Good prices and product, I shall return 😎👍
Good fresh cannabis , I’ll be back freak brother’s
blackcoffee19Anaheim
200% looking forward to it! Thanks so much!
Official response
How y'all can justify $28 for crap edibles...
I've been to this dispensary many times. Edibles are not worth $28!! Apparently, y'all believe they're better than others? THEY ARE NOT!!! Florida needs to take the THC cap off their products. The edibles here, never worked at all and I bought dab tabs and the freaking pen doesn't work. This dispensary is as bad as the rest in Gainesville Florida.
Jewelsrox777Gainesville
Dab tabs
I wanted to try dab tabs. This dispensary in Gainesville Florida, sold me the tabs and a little thing to put them in. I've had to go back to get a working battery only to get home and the battery is faulty. I will attempt one more time. The manager I spoke with on the phone was amazing but, the staff at the dispensary itself, are brainless and don't know what they're doing. Calling AGAIN, today to try and get this working. Will not return if I don't get help. I stopped going to this one awhile ago because they sold me a horrible batch of edibles. 2 Stars and I'm being kind.
Jewelsrox777Gainesville
So sorry to hear about your experience with our dab tabs! I hope you were able to find some success with your product. Please reach out to our store and ask to speak with management if not, we'll make sure you're satisfied! :)
Official response
Details
License information
Storefront
| Pickup
Medical
Amenities
Accessible
Age minimum
ATM
Medical
Security
Announcement
High quality strains available now!
SENIORS 15% Off
15% Off Total Purchase for 65
STUDENTS, VETERANS, SSI, SSDI, MEDICAID 15% Off Total Purchase
Use 1 promotion with 1 discount.
First-Time Customers
15% off Students, SSI, Senior, Medicare/Medicaid, Veterans
Promotions/Specials – Announcements:
New Patient Special – 20% off the total or $50 off of $150
Introduction
About Columbia Care Inc.
Columbia Care Inc. is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.2 million sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.
PEOPLE FIRST We aim to restore empathy in medicine to improve patient outcomes and overall health and wellness EXPERT ADVICE
Our patient-centric focus includes one-on-one consultations and follow-ups with pharmacists and experts, enabling individualized care on your personal health and wellness journey.
PRODUCTS WORTHY OF TRUST
With a focus on clean cultivation, superior quality, and positive patient outcomes, we offer brands and products that meet high standards of potency, purity, and predictability.
Our proprietary, patent-pending medical brands define Medical Cannabis. TheraCeed™, ClaraCeed™ and EleCeed™ are pharmaceutical-quality and come in a variety of formats, including hard-pressed tablets, suppositories, vapes, and lotions.
PATIENT TESTIMONIALS
With over one million patient interactions, we’re proud of the positive outcomes we’ve helped create. For powerful stories about how Columbia Care has impacted patients’ lives, click here.
RESEARCH AND DATA Fueling innovation and improving patient outcomes UNIVERSITY PARTNERSHIPS
We have established partnerships with some of the world’s leading research institutions, universities, and medical schools to further medical cannabis research, allowing for timely and relevant data collection and analysis, to drive future innovation.
PROPRIETARY DATA
We analyze patient and research data to identify new insights, that enable innovation in patient care and treatment, leading to new IP and improved patient experiences.
RELENTLESS INNOVATION
From products to service, we innovate to provide better products, patient experiences, and better patient outcomes.
#100MILLION INITIATIVE Columbia Care - Leading The Fight Against Opioids
Columbia Care is leading the fight against opioid addiction by helping to launch the #100Million initiative. Our CEO Nicholas Vita pledged to take 100 million doses of opioids off the street by leading a nationwide effort to gather the largest data set on how precisely-formulated medical cannabis can be a safe and effective alternative to reduce opioid use for pain.
LEADING THE INDUSTRY Columbia Care is leading the industry in product quality and expertise, as well as removing barriers to access for medical cannabis.
From introducing the U.S.’s first legal credit card for cannabis purchases, to starting the 100 million ways to break the opioid crisis research initiative, to advocating for access for patients of all types around the U.S. and the world, we have led the way in this industry and will continue to do so for the good of our business and our patients.
As an experienced multi-state operator, some of our key achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.
About us
BRINGING QUALITY, EXPERTISE
AND TRUST TO CANNABIS
We put patients and people first. By providing a portfolio of high-quality cannabis-based health and wellness solutions, leveraging data and research to fuel innovation, and improving access to cannabis and plant-based solutions, we aim to lead the industry.
Columbia Care Inc. is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU.
With over 1,000,000 successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.
With six-plus years of strong organic growth, disciplined operationalization of licenses, over 1 million sales transactions since inception, and having built 14 state-by-state vertically integrated operations, including 54 facilities in operation or development, and 35 licenses in 15 markets, we understand regulators, compliance, cultivation, manufacturing, quality control, physicians, caregivers, dispensaries, patients, and data inherent for success in this industry.
In addition to our medical cannabis products, we also offer a variety of health and wellness brands and products, including our own hemp CBD brands that are full spectrum, independent 3rd party tested, organic, GMO-free, and produced in cGMP-compliant facilities. Our flagship hemp CBD brand, Columbia Care Platinum Label, aims to set the standard in potency and purity.
COLUMBIA CARE LAUNCHES "100,000,000 WAYS TO BREAK THE OPIOID CRISIS" INITIATIVE
Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of nationwide study on medical cannabis’s impact on opioid use for pain
NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), a leading international medical cannabis company, today announced the launch of its new initiative, “100,000,000 Ways to Break the Opioid Crisis,” a nationwide effort to test whether precisely-formulated medical cannabis can be a safe and effective alternative to opioids for pain.
Columbia Care is kicking off the “100,000,000 Ways to Break the Opioid Crisis” initiative by providing its precisely-formulated pharmaceutical-quality cannabis-based medicines for a precedent-setting study to determine whether medical cannabis can reduce participants’ dependence on opioid use in managing pain. This study, which is being conducted at Montefiore Medical Center and Albert Einstein College of Medicine in the Bronx, will add to the body of knowledge to inform healthcare practices and public policies in this arena. The study is expected to be expanded to other hospitals throughout New York State and, ultimately, to other states where Columbia Care’s formulated medical cannabis products are also available.
Renowned addiction experts Dr. Chinazo Cunningham and Dr. Julia Arnsten, who are both researchers at Montefiore and Einstein, are leading the study.
DISCOVER HOW COLUMBIA CARE ARE DEVELOPING PRODUCTS TO MEET AN UNMET CLINICAL NEED IN WOMEN SUFFERING FROM PELVIC CONDITIONS.
As one of the nation’s most experienced producers of medical cannabis products, Columbia Care is committed to helping patients suffering from a wide range of state permitted qualifying conditions, including pelvic conditions.
It is a fact that female pelvic organs have a very high density of cannabinoid receptors (Brents, 2016). Current knowledge of the endocannabinoid system doesn’t explain the reason for this high number of receptors in the gynaecological urinary tract, but often this system is used to maintain a homeostatic balance in the body. The fact that the vagina has a mucous membrane that can readily absorb medicinal products makes vaginal suppositories uniquely suited to treating conditions affecting the women’s reproductive system, as they target the issue right at its source. It is also obvious that only quality products should be delivered in this manner to avoid irritation and additional inflammation.
The increased public awareness surrounding the use of cannabis for women’s health and the promising research discussed throughout this article put Columbia Care at the forefront of this movement with the debut of their pharmaceutical quality vaginal suppositories. This article summarises the existing scientific evidence regarding cannabis for women’s health concerns, and how these products are already transforming the treatment paradigm for women suffering from these conditions.
Columbia Care is constantly searching for new ways to address conditions associated with women’s health and as a result of these efforts, it has become one of the only medical cannabis companies to develop vaginal suppositories. These are the newest medicinal format addition to their proprietary portfolio of cannabis-based medicines, which already includes tinctures, vaporisation oils and hard-pressed tablets. All formulations are available for women’s health indications (within state guidelines), and for many of these conditions, such as insomnia, one of these traditional formats may be the best option. The vaginal suppositories are an important option for patients who may want rapid delivery of cannabinoids to the pelvic organs.
COLUMBIA CARE AND MOELLER PHARMA GMBH ENTER INTO EXCLUSIVE AGREEMENT TO DEVELOP PORTFOLIO OF PROPRIETARY, PLANT-BASED COMBINATION CANNABINOID FUNCTIONAL HEALTH AND WELLNESS PRODUCTS August 30, 2019
Columbia Care partners with FDA approved, GMP certified German developer and manufacturer of ultra-high quality herbal extracts, organic plant-based combination supplements and functional beverages with 75-year history of serving the pharmaceutical and food industries through its well established EU retail network of health food stores, drug stores, hypermarkets and independent pharmacies
R&D collaboration will provide the basis to develop a unique portfolio of products combining Columbia Care’s proprietary, pharmaceutical-quality cannabis-based formulations and Moeller’s deep repository of plant-derived botanical and homeopathic supplements and medicines
NEW YORK–(BUSINESS WIRE)–
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced that it has entered into an exclusive agreement with Moeller Pharma GmbH (“Moeller”), a GMP-certified German producer of high-quality herbal extracts, functional beverages and plant-derived combination supplements for the pharmaceutical and food industries, to develop a portfolio of proprietary cannabinoid-infused products to be sold globally, beginning with Europe and the US.
Moeller has been a trusted name in German households for more than 75 years, well known for the production and distribution of over 100 different high-quality fruit juices, plant-based functional drinks, supplements and other products sold through its established network of health food stores, drug stores and hypermarkets in Europe. Through its relationships with six of the largest German wholesalers, Moeller has access to over 22,000 independent pharmacies and retailers in Germany alone and currently produces more than 72 unique extracts and distillates of medicinal plants at scale for leading pharmaceutical companies. Moeller also possesses significant production capacity, currently extracting more than 600 metric tons of biomass per year at its state-of-the-art, FDA approved, Good Manufacturing Practice (GMP) certified facility in Germany.
Under the terms of the agreement, Columbia Care will contribute its GMP/GAP industrial hemp biomass, chemistry and extraction expertise as well as its cannabinoid extraction capabilities for use in health and wellness products while Moeller will provide its library of plant-based extracts, combination products, manufacturing capabilities, distribution channels and experience in creating popular functional consumer products for the global pharmaceutical, wellness and food markets. The parties will exclusively collaborate on research and development (R&D) efforts to develop a unique, patentable portfolio of cannabinoid-infused health and wellness products. Finished products will be manufactured under GMP conditions at Moeller’s German manufacturing facility.
Photos
See all 41 photos
Store details
Amenities
Accessible
Age minimum
ATM
Medical
Security
Introduction
About Columbia Care Inc.
Columbia Care Inc. is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.2 million sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.
PEOPLE FIRST We aim to restore empathy in medicine to improve patient outcomes and overall health and wellness EXPERT ADVICE
Our patient-centric focus includes one-on-one consultations and follow-ups with pharmacists and experts, enabling individualized care on your personal health and wellness journey.
PRODUCTS WORTHY OF TRUST
With a focus on clean cultivation, superior quality, and positive patient outcomes, we offer brands and products that meet high standards of potency, purity, and predictability.
Our proprietary, patent-pending medical brands define Medical Cannabis. TheraCeed™, ClaraCeed™ and EleCeed™ are pharmaceutical-quality and come in a variety of formats, including hard-pressed tablets, suppositories, vapes, and lotions.
PATIENT TESTIMONIALS
With over one million patient interactions, we’re proud of the positive outcomes we’ve helped create. For powerful stories about how Columbia Care has impacted patients’ lives, click here.
RESEARCH AND DATA Fueling innovation and improving patient outcomes UNIVERSITY PARTNERSHIPS
We have established partnerships with some of the world’s leading research institutions, universities, and medical schools to further medical cannabis research, allowing for timely and relevant data collection and analysis, to drive future innovation.
PROPRIETARY DATA
We analyze patient and research data to identify new insights, that enable innovation in patient care and treatment, leading to new IP and improved patient experiences.
RELENTLESS INNOVATION
From products to service, we innovate to provide better products, patient experiences, and better patient outcomes.
#100MILLION INITIATIVE Columbia Care - Leading The Fight Against Opioids
Columbia Care is leading the fight against opioid addiction by helping to launch the #100Million initiative. Our CEO Nicholas Vita pledged to take 100 million doses of opioids off the street by leading a nationwide effort to gather the largest data set on how precisely-formulated medical cannabis can be a safe and effective alternative to reduce opioid use for pain.
LEADING THE INDUSTRY Columbia Care is leading the industry in product quality and expertise, as well as removing barriers to access for medical cannabis.
From introducing the U.S.’s first legal credit card for cannabis purchases, to starting the 100 million ways to break the opioid crisis research initiative, to advocating for access for patients of all types around the U.S. and the world, we have led the way in this industry and will continue to do so for the good of our business and our patients.
As an experienced multi-state operator, some of our key achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.
About us
BRINGING QUALITY, EXPERTISE
AND TRUST TO CANNABIS
We put patients and people first. By providing a portfolio of high-quality cannabis-based health and wellness solutions, leveraging data and research to fuel innovation, and improving access to cannabis and plant-based solutions, we aim to lead the industry.
Columbia Care Inc. is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU.
With over 1,000,000 successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.
With six-plus years of strong organic growth, disciplined operationalization of licenses, over 1 million sales transactions since inception, and having built 14 state-by-state vertically integrated operations, including 54 facilities in operation or development, and 35 licenses in 15 markets, we understand regulators, compliance, cultivation, manufacturing, quality control, physicians, caregivers, dispensaries, patients, and data inherent for success in this industry.
In addition to our medical cannabis products, we also offer a variety of health and wellness brands and products, including our own hemp CBD brands that are full spectrum, independent 3rd party tested, organic, GMO-free, and produced in cGMP-compliant facilities. Our flagship hemp CBD brand, Columbia Care Platinum Label, aims to set the standard in potency and purity.
COLUMBIA CARE LAUNCHES "100,000,000 WAYS TO BREAK THE OPIOID CRISIS" INITIATIVE
Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of nationwide study on medical cannabis’s impact on opioid use for pain
NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), a leading international medical cannabis company, today announced the launch of its new initiative, “100,000,000 Ways to Break the Opioid Crisis,” a nationwide effort to test whether precisely-formulated medical cannabis can be a safe and effective alternative to opioids for pain.
Columbia Care is kicking off the “100,000,000 Ways to Break the Opioid Crisis” initiative by providing its precisely-formulated pharmaceutical-quality cannabis-based medicines for a precedent-setting study to determine whether medical cannabis can reduce participants’ dependence on opioid use in managing pain. This study, which is being conducted at Montefiore Medical Center and Albert Einstein College of Medicine in the Bronx, will add to the body of knowledge to inform healthcare practices and public policies in this arena. The study is expected to be expanded to other hospitals throughout New York State and, ultimately, to other states where Columbia Care’s formulated medical cannabis products are also available.
Renowned addiction experts Dr. Chinazo Cunningham and Dr. Julia Arnsten, who are both researchers at Montefiore and Einstein, are leading the study.
DISCOVER HOW COLUMBIA CARE ARE DEVELOPING PRODUCTS TO MEET AN UNMET CLINICAL NEED IN WOMEN SUFFERING FROM PELVIC CONDITIONS.
As one of the nation’s most experienced producers of medical cannabis products, Columbia Care is committed to helping patients suffering from a wide range of state permitted qualifying conditions, including pelvic conditions.
It is a fact that female pelvic organs have a very high density of cannabinoid receptors (Brents, 2016). Current knowledge of the endocannabinoid system doesn’t explain the reason for this high number of receptors in the gynaecological urinary tract, but often this system is used to maintain a homeostatic balance in the body. The fact that the vagina has a mucous membrane that can readily absorb medicinal products makes vaginal suppositories uniquely suited to treating conditions affecting the women’s reproductive system, as they target the issue right at its source. It is also obvious that only quality products should be delivered in this manner to avoid irritation and additional inflammation.
The increased public awareness surrounding the use of cannabis for women’s health and the promising research discussed throughout this article put Columbia Care at the forefront of this movement with the debut of their pharmaceutical quality vaginal suppositories. This article summarises the existing scientific evidence regarding cannabis for women’s health concerns, and how these products are already transforming the treatment paradigm for women suffering from these conditions.
Columbia Care is constantly searching for new ways to address conditions associated with women’s health and as a result of these efforts, it has become one of the only medical cannabis companies to develop vaginal suppositories. These are the newest medicinal format addition to their proprietary portfolio of cannabis-based medicines, which already includes tinctures, vaporisation oils and hard-pressed tablets. All formulations are available for women’s health indications (within state guidelines), and for many of these conditions, such as insomnia, one of these traditional formats may be the best option. The vaginal suppositories are an important option for patients who may want rapid delivery of cannabinoids to the pelvic organs.
COLUMBIA CARE AND MOELLER PHARMA GMBH ENTER INTO EXCLUSIVE AGREEMENT TO DEVELOP PORTFOLIO OF PROPRIETARY, PLANT-BASED COMBINATION CANNABINOID FUNCTIONAL HEALTH AND WELLNESS PRODUCTS August 30, 2019
Columbia Care partners with FDA approved, GMP certified German developer and manufacturer of ultra-high quality herbal extracts, organic plant-based combination supplements and functional beverages with 75-year history of serving the pharmaceutical and food industries through its well established EU retail network of health food stores, drug stores, hypermarkets and independent pharmacies
R&D collaboration will provide the basis to develop a unique portfolio of products combining Columbia Care’s proprietary, pharmaceutical-quality cannabis-based formulations and Moeller’s deep repository of plant-derived botanical and homeopathic supplements and medicines
NEW YORK–(BUSINESS WIRE)–
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced that it has entered into an exclusive agreement with Moeller Pharma GmbH (“Moeller”), a GMP-certified German producer of high-quality herbal extracts, functional beverages and plant-derived combination supplements for the pharmaceutical and food industries, to develop a portfolio of proprietary cannabinoid-infused products to be sold globally, beginning with Europe and the US.
Moeller has been a trusted name in German households for more than 75 years, well known for the production and distribution of over 100 different high-quality fruit juices, plant-based functional drinks, supplements and other products sold through its established network of health food stores, drug stores and hypermarkets in Europe. Through its relationships with six of the largest German wholesalers, Moeller has access to over 22,000 independent pharmacies and retailers in Germany alone and currently produces more than 72 unique extracts and distillates of medicinal plants at scale for leading pharmaceutical companies. Moeller also possesses significant production capacity, currently extracting more than 600 metric tons of biomass per year at its state-of-the-art, FDA approved, Good Manufacturing Practice (GMP) certified facility in Germany.
Under the terms of the agreement, Columbia Care will contribute its GMP/GAP industrial hemp biomass, chemistry and extraction expertise as well as its cannabinoid extraction capabilities for use in health and wellness products while Moeller will provide its library of plant-based extracts, combination products, manufacturing capabilities, distribution channels and experience in creating popular functional consumer products for the global pharmaceutical, wellness and food markets. The parties will exclusively collaborate on research and development (R&D) efforts to develop a unique, patentable portfolio of cannabinoid-infused health and wellness products. Finished products will be manufactured under GMP conditions at Moeller’s German manufacturing facility.
First-Time Customers
15% off Students, SSI, Senior, Medicare/Medicaid, Veterans
Promotions/Specials – Announcements:
New Patient Special – 20% off the total or $50 off of $150
Reviews
0 ratings | 11 reviews